Susquehanna International Group’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Buy |
138,460
+64,551
| +87% | +$246K | ﹤0.01% | 4253 |
|
|
2025
Q1 | $194K | Buy |
73,909
+52,643
| +248% | +$138K | ﹤0.01% | 5530 |
|
|
2024
Q4 | $75.3K | Buy |
21,266
+2,500
| +13% | +$8.85K | ﹤0.01% | 5770 |
|
|
2024
Q3 | $85.6K | Sell |
18,766
-5,169
| -22% | -$23.6K | ﹤0.01% | 5166 |
|
|
2024
Q2 | $104K | Sell |
23,935
-2,953
| -11% | -$12.8K | ﹤0.01% | 5086 |
|
|
2024
Q1 | $135K | Sell |
26,888
-37,829
| -58% | -$190K | ﹤0.01% | 4888 |
|
|
2023
Q4 | $406K | Buy |
64,717
+40,226
| +164% | +$252K | ﹤0.01% | 4135 |
|
|
2023
Q3 | $174K | Sell |
24,491
-61,164
| -71% | -$435K | ﹤0.01% | 4627 |
|
|
2023
Q2 | $873K | Sell |
85,655
-140,998
| -62% | -$1.44M | ﹤0.01% | 2913 |
|
|
2023
Q1 | $2.06M | Buy |
226,653
+135,446
| +149% | +$1.23M | ﹤0.01% | 1928 |
|
|
2022
Q4 | $654K | Buy |
91,207
+28,049
| +44% | +$201K | ﹤0.01% | 2850 |
|
|
2022
Q3 | $412K | Sell |
63,158
-9,465
| -13% | -$61.7K | ﹤0.01% | 3805 |
|
|
2022
Q2 | $350K | Buy |
72,623
+31,934
| +78% | +$154K | ﹤0.01% | 3790 |
|
|
2022
Q1 | $231K | Buy |
+40,689
| New | +$231K | ﹤0.01% | 4657 |
|
|
2020
Q2 | – | Sell |
-11,759
| Closed | -$87K | – | 4836 |
|
|
2020
Q1 | $87K | Buy |
+11,759
| New | +$87K | ﹤0.01% | 4082 |
|
|
2019
Q1 | – | Sell |
-17,711
| Closed | -$67K | – | 4324 |
|
|
2018
Q4 | $67K | Buy |
+17,711
| New | +$67K | ﹤0.01% | 3278 |
|